A novel investigational allogeneic stem cell-derived treatment resulted in near reversal of type 1 diabetes in a patient who had lived with the condition for about 40 years. The patient was the first in Vertex Pharmaceuticals’ phase 1/2 multicenter, single-arm, open-label clinical trial of the insulin-producing islet cell therapy VX-880 for patients with type 1 […]
The American Association of Clinical Endocrinology (AACE) has issued its first-ever official guidelines addressing the use of advanced technologies in the management of people with diabetes. The guidelines cover use of continuous glucose monitoring (CGM), insulin pumps, connected pens, automated insulin delivery systems, telemedicine technologies, and smartphone apps. They also address safety considerations, special situations […]
The prevalence of type 1 diabetes among transgender and gender diverse patients is higher than in the general population, research suggests. This has been reported by three groups. In two studies, the cohort comprised children; in the other, older adults. One article documents a nearly fivefold higher rate of type 1 diabetes among youths who […]
